Marijke Stigter‐van Walsum

Author

Amsterdam UMC Location Vrije Universiteit Amsterdam ORCID

Also Known As

M. Stigter-van Walsum, Marijke Stigter van Walsum, Marijke Stigter-Van Walsum, Marijke Stigter-van Walsum, Marijke Stigter‐Van Walsum, Marijke Stigter‐van Walsum, Stigter-van Walsum, M

149

Publications

2.8K

Citations

H-Index

Concepts

All Affiliations

Amsterdam UMC Location Vrije Universiteit Amsterdam Vrije Universiteit Amsterdam Utrecht University Ablynx (Belgium)Bayer (Germany)

About

Marijke Stigter‐van Walsum is an author at Amsterdam UMC Location Vrije Universiteit Amsterdam specializing in medicine, cancer research, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	13	1.4K
2	Engineering	6	6	893
3	Health Sciences	3	3	384
4	Natural Sciences	1	1	71
5	Biochemistry	1	1	71

Marijke Stigter‐van Walsum

Publications

2.8K

Citations

H-Index

Page 1

	Year	Citations
Improved tumor targeting of anti–epidermal growth factor receptor Nanobodies through albumin binding: taking advantage of modular Nanobody technology Bernard M. Tijink, Toon Laeremans, Marianne Budde, Molecular Cancer Therapeutics NanoparticlesNanotherapeuticsEngineeringImmunologyTaking Advantage	2008	289
(89)Zr as a PET surrogate radioisotope for scouting biodistribution of the therapeutic radiometals (90)Y and (177)Lu in tumor-bearing nude mice after coupling to the internalizing antibody cetuximab. Lars R. Perk, Gerard W.M. Visser, Maria J.W.D. Vosjan, PubMed	2005	205
Rapid Visualization of Human Tumor Xenografts through Optical Imaging with a Near-Infrared Fluorescent Anti–Epidermal Growth Factor Receptor Nanobody Sabrina Oliveira, Guus A.M.S. van Dongen, Marijke Stigter‐van Walsum, Molecular Imaging EngineeringOncologic ImagingPathologyBiomedical EngineeringHuman Tumor Xenografts	2012	188
The Human Cytomegalovirus–Encoded Chemokine Receptor US28 Promotes Angiogenesis and Tumor Formation via Cyclooxygenase-2 David Maussang, Ellen Langemeijer, Carlos P. Fitzsimons, Cancer Research InflammationCancer ResearchCancer ImmunosurveillanceUs28 ExpressionMedicine	2009	171
Preparation and evaluation of 89Zr-Zevalin for monitoring of 90Y-Zevalin biodistribution with positron emission tomography Lars R. Perk, Otto Visser, Marijke Stigter‐van Walsum, European Journal of Nuclear Medicine and Molecular Imaging Positron Emission TomographyEngineeringMedical ImagingSpectroscopyAnalytical Chemistry	2006	159
Llama-derived Single Variable Domains (Nanobodies) Directed against Chemokine Receptor CXCR7 Reduce Head and Neck Cancer Cell Growth in Vivo David Maussang, Azra Mujić-Delić, Francis J. Descamps, Journal of Biological Chemistry	2013	140
Nanobodies Targeting the Hepatocyte Growth Factor: Potential New Drugs for Molecular Cancer Therapy Maria J.W.D. Vosjan, Jo Vercammen, Joost A. Kolkman, Molecular Cancer Therapeutics NanoparticlesNanotherapeuticsEngineeringTumor Growth DelayPotential New Drugs	2012	135
Long-Lived Positron Emitters Zirconium-89 and Iodine-124 for Scouting of Therapeutic Radioimmunoconjugates with PET Iris Verel, Gerard W.M. Visser, Otto C. Boerman, Cancer Biotherapy and Radiopharmaceuticals Oncologic ImagingImmunotherapyAntibody-pet ImagingPositron Emission TomographyRadiation Medicine	2003	127
Facile labelling of an anti-epidermal growth factor receptor Nanobody with 68Ga via a novel bifunctional desferal chelate for immuno-PET Maria J.W.D. Vosjan, Lars R. Perk, Rob C. Roovers, European Journal of Nuclear Medicine and Molecular Imaging	2011	106
Radioimmunotherapy of head and neck cancer xenografts using 131I-labeled antibody L19-SIP for selective targeting of tumor vasculature. Bernard M. Tijink, Dario Neri, C. René Leemans, PubMed	2006	104

Page 1